Jouni Kyllönen has been appointed as the new CEO of Thermidas. He will start in the position on January 1st 2023. Prior to the appointment, Kyllönen worked as the Sales and Marketing Director for Thermidas.
The current CEO Raimo Mansikkaoja will continue with us as a Senior Advisor.
Thermidas has now an approved European patent for the thermal imaging method. The method was developed for medical purposes and is certified (CE/FDA) as a so-called medical device. The system analyzes differences in skin surface temperatures in time and place (on the body or part of it). The obtained thermal image information provided by the…
Thermidas received a perfect 10/10 score from the Digi-HTA assessment. The key assessment domains are: Effectiveness Safety Cost Data security and protection Usability and accessibility Digi-HTA is a method developed for digital products and services for social and health care and well-being. It is used to assess the suitability of a product or service for…
TherMidas is one of the exhibitors at the MEDICA 2021 international trade fair in Düsseldorf, Germany. MEDICA is the world’s largest event for the medical sector with about 2.900 exhibitors from 70 different nations. Kari Kaunisharju and Stephen Taylor will be at our booth (Hall 4 / J39) during the whole event to display our…
An internationally unique study will begin in Tampere to monitor hockey players’ injuries and rehabilitation using thermal imaging. Markku Tuominen, sports physician at Medisport, will conduct the study using Thermidas’ thermal imaging system. The study will involve the entire Ilves U18 hockey team. Thermal imaging has been studied before as a tool for monitoring athletes’…
Thermidas is one of the few companies to be chosen for MedTech Innovator‘s 2023 accelerator program. More than 1,000 companies applied to participate in the 2023 Accelerator. From that group, MedTech Innovator with its corporate partners and industry judges, advanced nearly 200 candidates to in-person pitch and partnering events. Finally, only 61 companies got a place…
Type 2 Diabetes Mellitus is a well-known challenge in the Middle East region. The Finnish Thermidas and Novasvia in the United Arab Emirates enter the Health Care Thermal Imaging markets in the MENA region. The spearheads are from early diagnostics of diabetes complications to effective follow-up treatment. The prevalence of Type 2 Diabetes among Emirati…